The objective of this study was to determine the risk factors related to diabetic macroangiopathy. This was a cross-sectional study with a descriptive and analytical aim over a period of six (06) months from January 1, 2022 to June 30, 2023 including 100 patients with type 2 diabetes with or without complications received in consultation and/or hospitalized in the cardiology and diabetology department of the National Reference University Hospital Center. The patients benefited from a meticulous questioning, a complete somatic examination and a biological assessment including in particular the dosage of dyslipidemia. The 100 subjects included in this study were categorized into group 1 with complications (n = 48) and group 2 without complications (n = 52). The prevalence of macroangiopathy was 48%. The mean age of the patients was 62.21 years for group 1 versus 61.94 years for group 2. The male sex was predominant in both groups with the overall sex ratio of 1.85 or 2.4 for group 1 versus 1.5 for group 2. The mean waist circumference was 100.13 ± 11.5 for group 1 versus 90.12 ± 8.7 for group 2. The mean fasting blood glucose was 2.9 ± 0.6 in group 1 versus 2.2 ± 0.32 for group 2. High blood pressure and smoking were predominant in group 1. The mean glycated hemoglobin was 9.6 ± 1.7 for group 1 versus 7.4 ± 0.6 for group 2. Most patients in group 1 were not undergoing medical monitoring of their diabetes and were on insulin, unlike subjects in group 2 who were on oral antidiabetics and were adhering to medical monitoring. Prevention of macroangiopathy in type 2 diabetic patients involves early screening of blood sugar, glycated hemoglobin and all cardiovascular risk factors.
References
[1]
Drouin, P., Blickle, J.F., Charbonnel, B., Eschwege, E., Guillausseau, P.J. and Plouin, P.F. (1999) Diagnosis and Classification of Diabetes Mellitus the New Criteria. Diabetes&Metabolism, 25, 72-83.
[2]
International Diabetes Federation (2022) Diabetes Atlas 9th Edition. http://www.diabetesatlas.org
[3]
Fosse-Edorh, S., Guion, M., Goria, S., Mandereau-Bruno, L. and Cosson, E. (2025) Dynamics of Diabetes Prevalence, Incidence and Mortality in France: A Nationwide Study, 2013-2021. Diabetes & Metabolism, 51, Article ID: 101615. https://doi.org/10.1016/j.diabet.2025.101615
[4]
Dionadji, M., Boy, B., Nodjito, M. and Ibrahim, A. (2015) Prevalence of Medical Complications among Diabetics Hospitalized at the National General Reference Hospital of N’Djamena. HeathScienceDisease, 1, 4.
[5]
Bessimbaye, N., Ouassalet, B.E., Ali, S.M., Abdelsalam, T. and Choua, O. (2023) Resistance Phenotypes and Epidemiological Profile of Bacteria Isolated from Diabetic Wounds in the Endocrinology Department of the National Reference University Hospital of N’Djamena, Chad. InternationalJournalofInnovationScientificResearchandReview, 5, 5456-5462.
[6]
Dioum, M., Ndiaye, P.N., Mingou, J.S., Ba, M.F., Bamba Diop, C.H., Bodian, M., Diack, B., Bamba Ndiaye, M. and Diao, M. (2021) La coronarographie chez les patients diabétiques: Étude rétrospective à propos de 101 cas colligés au centre de cardiologie interventionnelle du Centre Hospitalier Universitaire Aristide Le Dantec de Dakar. International Journal of Cardiology, 164, 162-166. http://tropical-cardiology.com/Accueil/index.php/fr/2013-08-10-06-44-55/annee-2021/n-164-avr-mai-juin-2021/397-la-coronarographie-chez-les-patients-diabetiques-etude-retrospective-a-propos-de-101-cas-colliges-au-centre-de-cardiologie-interventionnelle-du-centre-hospitalier-universitaire-aristide-le-dantec-de-dakar
[7]
Sebai, I., Oueslati, I., Khessairi, N., Yazidi, M., Talbi, E. and Chaker, F. (2019) Predictive Factors of Macroangiopathy in Type 2 Diabetics. Louvain Médical, 138, 466-472.
[8]
Kamel, M., Laure, A. and Laurence, V. (2018) Obliterative Arteriopathies of the Lower Limbs in Diabetic Patients. Correspondences in Metabolisms. Hormones Diabetes and Nutrition, XXII-n3, 4.
[9]
Imen, S., Ibtissem, O., Nadia, K., Meriem, Y., Emna, T., Fatma, C.M.C., et al. (2019) Predictive Factors of Macroangiopathy in Type 2 Diabetics. Louvain Médical, 138, 466-467.
[10]
Camara, D. (2022) Strokes in Type 2 Diabetes in the Internal Medicine Department of CHU-PG. Thesis, FMOS de Bamako, 66 p.
[11]
Lehto, S., Rönnemaa, T., Haffher, S.M., Pyörälä, K., Kallio, V. and Laakso, M. (1997) Dyslipidemia and Hyperglycemia Predict Coronary Heart Disease Events in Middle-Aged Patients with NIDDM. Diabetes, 46, 1354-1359. https://doi.org/10.2337/diab.46.8.1354
[12]
Mbaye, M., Niang, K., Sarr, A., Mbaye, A., Diedhiou, D., Ndao, M., et al. (2011) Epidemiological Aspects of Diabetes in Senegal: Results of a Survey on Cardiovascular Risk Factors in the City of Saint-Louis. Medicine of Metabolic Diseases, 5, 659-664.
[13]
Sassor Odile Purifine, A. (2017) Macroangiopathy and Associated Factors in Outpatients with Type 2 Diabetes Attending the Antidiabetic Center of Abidjan in Ivory Coast. Science Journal of Public Health, 5, 347-352. https://doi.org/10.11648/j.sjph.20170504.21
[14]
Konaté, M., Sow, D.S., Traoré, D., Diakité, A., Ouologuem, N., Kané, O., et al. (2018) Macroangiopathic Complications of Diabetes at the Mali Hospital in Bamako. Journal of Scientific Research of the University of Lomé, 20, 483-492.
[15]
Tuomilehto, J. (2004) Impact of Age on Cardiovascular Risk: Implications for Cardiovascular Disease Management. AtherosclerosisSupplements, 5, 9-17. https://doi.org/10.1016/j.atherosclerosissup.2004.03.006
[16]
Dembele, S. (2023) Monitoring of Diabetics in Bamako. Medical Thesis, Faculty of Medicine and Odontostomatology of Bamako, 7 p.
[17]
Derrazi, C. (2020) Particularities of Diabetic Coronary Artery Disease in the Cardiology Department of HMA Marrakech. Med. Thesis, Faculty of Medicine and Pharmacy-Marrakech, 11 p.
[18]
Lee, W.L., Cheung, A.M., Cape, D. and Zinman, B. (2000) Impact of Diabetes on Coronary Artery Disease in Women and Men: A Meta-Analysis of Prospective Studies. DiabetesCare, 23, 962-968. https://doi.org/10.2337/diacare.23.7.962
[19]
Chaâbane, A., Rekik, N., Graja, S. and Mnif, M. (2013) Coronary Artery Disease and Diabetes. Diabetes & Metabolism, 39, 72.
[20]
Dinia, M. (2016) Profile of Diabetic Coronary Artery Disease at the Avicenna Hospital in Rabat Med V University, Faculty of Medicine and Pharmacy Rabat 2016 Thesis Number 220/17.
[21]
Lee, J.W., Lim, N., Lee, J.H. and Park, H. (2016) OS 22-03 Joint Effect of Pre-Existing Hypertension and Diabetes on Cardiovascular Diseases and Mortality in the Middle-Aged Koreans. JournalofHypertension, 34, e238-e239. https://doi.org/10.1097/01.hjh.0000500531.11953.1f
[22]
Redon, J., Cifkova, R., Laurent, S., Nilsson, P., Narkiewicz, K., Erdine, S., et al. (2009) Mechanisms of Hypertension in the Cardiometabolic Syndrome. JournalofHypertension, 27, 441-451. https://doi.org/10.1097/hjh.0b013e32831e13e5
[23]
Kengne, A.P. and Echouffo-Tcheugui, J.B. (2021) Utility of Models for Estimating Cardio-Vascular Risk in People with Diabetes. Sang Thrombose Vaisseaux, 23, 292-298.
[24]
Hakimi, M. (2015) Influence of Diabetes on the Prognosis of Acute Coronary Syndromes CADI AYYAD University, Faculty of Medicine and Pharmacy Marrakech 2015 Thesis Number 16/15.
[25]
Amoussou-Guenou, K.D. (2018) Morbidity of Diabetic Foot in Internal Medicine at CNHU HKM in Cotonou. Mali Medical, 21, 44-47.
[26]
Tangara, M. (2022) Cardiovascular Complications during Diabetes at Gabriel Touré Hospital (Cardiology). Med Thesis, Faculty of Medicine and Odontostomatology of Bamako, No. 183.
[27]
Sabry, M., Benyass, A.Z., Raissouni, M., Kendoussi, M., Moustaghfir, A., Zbir, M., Hda, A., Boukili, A. and Hamani, A. (2006) Myocardial Infarction in Diabetics. La Presse Médicale, 5, 207-211.
[28]
Fatini, C., Sticchi, E., Bolli, P., Marcucci, R., Giusti, B., Paniccia, R., et al. (2011) Platelet Aggregability Is Modulated by eNOS Locus in Non-Type 2 Diabetic Patients with Acute Coronary Syndrome. Nutrition, MetabolismandCardiovascularDiseases, 21, 11-17. https://doi.org/10.1016/j.numecd.2009.07.001
[29]
Journal of Hypertension (JAMA) (2003) Recommendations of the European Society of Hypertension and the European Society of Cardiology for the Management of Arterial Hypertension. Medical Thesis, Recommendations Development Committee, 52. http://www.jhypertension.com
[30]
Coulibaly, I. (2010) Study of Cardiovascular Risk Factors in Diabetic Patients in Bamako. Thesis, Med. Bamako, 78 p.
[31]
Motreff, R. (2005) Cardiovascular Risk Factors: Cardiology and Vascular Diseases Department, Clermont-Ferrand University Hospital ADLF Study Days, 2, 01-02.
[32]
Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F.L., Powe, N.R., et al. (2004) Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus. AnnalsofInternalMedicine, 141, 421-431. https://doi.org/10.7326/0003-4819-141-6-200409210-00007
[33]
Stratton, I.M., Adler, A.I. and Neil, H.A. (2000) Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study. BMJ, 321, 405-412. https://doi.org/10.1136/bmj.321.7258.405
[34]
Meyer, M., Lieps, D., Schatz, H., Klein, H. and Pfohl, M. (2008) Influence of the Duration of Type 2 Diabetes on Early Functional and Morphological Markers of Atherosclerosis Compared to the Impact of Coexisting Classic Cardiovascular Risk Factors. ExperimentalandClinicalEndocrinology&Diabetes, 116, 298-304. https://doi.org/10.1055/s-2008-1042404
[35]
Yokoyama, H., Yoshitake, E., Otani, T., Uchigata, Y., Kawagoe, M., Kasahara, T., et al. (1993) Carotid Atherosclerosis in Young-Aged IDDM Associated with Diabetic Retinopathy and Diastolic Blood Pressure. DiabetesResearchandClinicalPractice, 21, 155-159. https://doi.org/10.1016/0168-8227(93)90063-b
[36]
Damoune, I., Aziouaz, F., El. Ouahabi, H. and Ajdi, F. (2014) P32 Dyslipidémie et facteurs de risques cardiovasculaires chez le diabétique de type 2. Diabetes&Metabolism, 40, A37. https://doi.org/10.1016/s1262-3636(14)72326-2
[37]
Goulahssen, A. (2016) Epidemiological, Clinical, Angiographic and Evolutionary Profile of Ischemic Heart Disease in Diabetics at the CHU Med VI of Marrakech. Thesis Number 77/16, CADI AYYAD University, Faculty of Medicine and Pharmacy.
[38]
Ben Ahmed, H., Bouzid, K., Hassine, M., Saadi, O., Bahlous, A., Abdelmoula, J., et al. (2014) Prevalence of Unconventional Cardiovascular Risk Factors in Tunisian Diabetic Subjects. LaPresseMédicale, 43, e9-e16.
[39]
Aronson, D. and Edelman, E.R. (2016) Coronary Artery Disease and Diabetes Mellitus. Heart Failure Clinics, 12, 117-133. https://doi.org/10.1016/j.hfc.2015.08.010
[40]
UKPDS Prospective Diabetes Study Group (1998) Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). The Lancet, 352, 837-853.